MYND Life Sciences

Kelowna, Canada

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

$1.6M raised

Feb 2025

Post-IPO Equity

Life Science Pharmaceutical Wellness

Top Investors

National Research Council of Canada Industrial Research Assistance Program

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MYND Life Sciences

How much funding has MYND Life Sciences raised?

MYND Life Sciences has raised $1.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.

Who are MYND Life Sciences's investors?

MYND Life Sciences's investors include National Research Council of Canada Industrial Research Assistance Program.

Where is MYND Life Sciences headquartered?

MYND Life Sciences is headquartered in Kelowna, Canada.

What does MYND Life Sciences do?

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

What stage is MYND Life Sciences at?

MYND Life Sciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 11, 2025.

MLA

"MYND Life Sciences — Funding & Investors." VCBacked, February 11, 2025, https://www.vcbacked.co/company/mynd-life-sciences. Accessed July 3, 2026.

APA

VCBacked. (2025). MYND Life Sciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/mynd-life-sciences

Wikipedia (cite web)

{{cite web |title=MYND Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/mynd-life-sciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 11, 2025.

Similar Companies in Life Science

Neuroglee Therapeutics